Showing results (651-660 of 998) with videos related to
Sort By:
Pageof 100
Journal of Clinical Pathology|January 6, 2006
Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumoursC Van Poznak, S S Cross, M Saggese, et al.Oncogene|March 21, 2006
Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancerA Leiblich, S S Cross, J W F Catto, et al.Journal of Clinical Medicine|September 28, 2024
Phenotype and Treatment Options for Mesenteric Lymph Node Cavitating Syndrome in Coeliac Disease: A Case Series and Literature ReviewFederica Marchetti, Suneil A Raju, Nicoletta Nandi, et al.Histopathology|September 3, 2011
Angiopoietins 1 and 2 and Tie-2 receptor expression in human ductal breast diseaseCarolyn A Staton, Leslie Hoh, Alice Baldwin, et al.Nature|July 9, 1987
The mapping of a cDNA from the human X-linked Duchenne muscular dystrophy gene to the mouse X chromosomeN Brockdorff, G S Cross, J S Cavanna, et al.Journal of Hepatocellular Carcinoma|May 8, 2023
Outcomes of National Survey of the Practice of Hepatocellular Carcinoma SurveillanceRobert A Scott, Timothy J S Cross, Christopher Clarke, et al.British Journal of Cancer|March 19, 2024
Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortalityAnya Burton, Jennifer Wilburn, Robert J Driver, et al.Experimental Cell Research|May 25, 2002
Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3)Petra Bareis, Enikö Kállay, Martin G Bischof, et al.Gut|June 15, 2007
The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancerCarolyn A Staton, Andrew S A Chetwood, Iain C Cameron, et al.The Journal of Infectious Diseases|June 1, 1996
Potential hazards of combination immunotherapy in the treatment of experimental septic shockS M Opal, A S Cross, J W Jhung, et al.Pageof 100